Evidence map›Paper›PMID 40437545›Full record

ReviewItalian journal of pediatrics2025

The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.

Maddalena Casale, Silvia Benemei, Cristiano Gallucci, Giovanna Graziadei, Giovanni Battista Ferrero

Abstract readReview
In one paragraph

Review in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maddalena CasaleDepartment of Woman, Child and General and Specialized Surgery, "Luigi Vanvitelli" Università degli Studi della Campania, Naples, Italy.
Silvia BenemeiMedical Affairs, Pfizer Italy, Rome, Italy. silvia.benemei@pfizer.com.
Cristiano GallucciMedical Affairs, Pfizer Italy, Rome, Italy.
Giovanna Graziadei *SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Giovanni Battista Ferrero *Department of Clinical and Biological Science, University of Torino, Torino, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) is an inherited autosomal recessive monogenic blood disorder characterized by red blood cell sickling responsible for recurrent vaso-occlusive crises and chronic hemolysis. Clinical manifestations vary and SCD patients experience increased morbidity and mortality. In Italy, SCD patients cluster into two distinct subpopulations: those of sub-Saharan African descent and those of Caucasian descent. Most sub-Saharan African SCD patients are children or young adults and carry the homozygous genotype hemoglobin (Hb) S, or SC, whereas Caucasian SCD patients tend to be older and have predominantly HbS/β-thalassemia. Patients of African descent typically present with acute SCD-related events, including vaso-occlusive crises, acute chest syndrome, anemia, fever, and pneumonia. Caucasian patients, according to the different distribution of SCD genotypes, may exhibit either acute episodes or chronic long-term complications. Regardless of age, genotype, or ethnic background, most SCD patients in Italy are undiagnosed, and pain, fatigue and anemia should be regarded as presenting signs and symptoms of this disease. The tests needed to diagnose SCD are simple, and a complete blood count together with erythrocyte morphology, wherever available, hemolysis markers, should be performed whenever SCD is suspected. If a patient presents with two risk factors -family history, ethnicity, or a significant clinical feature - a first-level screening test (e.g. assessment of Hb fractions with HPLC), where available, should be performed immediately, or a referral should be provided. Here, we present an overview of the clinical features of SCD that may be encountered in real-world clinical practice in Italy from a practical perspective. This narrative review may aid non-specialist physicians in identifying disparate clinical conditions that may be symptoms or signs of SCD.

Indexed as

Anemia, Sickle CellChildHumansItalyMalePhenotypeAnemiaClinical phenotypesFatigueHemoglobin variantsPainSickle cell disease (SCD)Thalassemia

Identifiers

PMID40437545
PMCPMC12121258

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.